Skip to main content
editorial
. 2020 Jul 25;5(9):1377–1380. doi: 10.1016/j.ekir.2020.07.024

Figure 1.

Figure 1

Approaches to maintaining hemofilter patency, with modifications for those with coronavirus disease 2019 (COVID-19). LMWH, low molecular weight heparin; UFH, unfractionated heparin. ∗Monitoring range should be locally determined, suggested by Ronco et al.7